Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population

Detalles Bibliográficos
Autores principales: O’Quinn, John, Santucci, Stephanie, Pham, Diana, Chad, Zave, MacLusky, Ian, Reisman, Joseph, Yang, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304085/
http://dx.doi.org/10.1186/1710-1492-10-S2-A34
_version_ 1782354032897032192
author O’Quinn, John
Santucci, Stephanie
Pham, Diana
Chad, Zave
MacLusky, Ian
Reisman, Joseph
Yang, William
author_facet O’Quinn, John
Santucci, Stephanie
Pham, Diana
Chad, Zave
MacLusky, Ian
Reisman, Joseph
Yang, William
author_sort O’Quinn, John
collection PubMed
description
format Online
Article
Text
id pubmed-4304085
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43040852015-02-12 Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population O’Quinn, John Santucci, Stephanie Pham, Diana Chad, Zave MacLusky, Ian Reisman, Joseph Yang, William Allergy Asthma Clin Immunol Meeting Abstract BioMed Central 2014-12-18 /pmc/articles/PMC4304085/ http://dx.doi.org/10.1186/1710-1492-10-S2-A34 Text en Copyright © 2014 O’Quinn et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
O’Quinn, John
Santucci, Stephanie
Pham, Diana
Chad, Zave
MacLusky, Ian
Reisman, Joseph
Yang, William
Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
title Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
title_full Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
title_fullStr Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
title_full_unstemmed Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
title_short Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
title_sort omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304085/
http://dx.doi.org/10.1186/1710-1492-10-S2-A34
work_keys_str_mv AT oquinnjohn omalizumabtreatmentofmoderatetosevereasthmaintheadolescentandpediatricpopulation
AT santuccistephanie omalizumabtreatmentofmoderatetosevereasthmaintheadolescentandpediatricpopulation
AT phamdiana omalizumabtreatmentofmoderatetosevereasthmaintheadolescentandpediatricpopulation
AT chadzave omalizumabtreatmentofmoderatetosevereasthmaintheadolescentandpediatricpopulation
AT macluskyian omalizumabtreatmentofmoderatetosevereasthmaintheadolescentandpediatricpopulation
AT reismanjoseph omalizumabtreatmentofmoderatetosevereasthmaintheadolescentandpediatricpopulation
AT yangwilliam omalizumabtreatmentofmoderatetosevereasthmaintheadolescentandpediatricpopulation

Ejemplares similares